• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec4
Galmed Pharmaceuticals Grants New Use Patent for ARAMCHOL in Combination with Madrigal Pharmaceuticals' REZDIFFRA
13:35
Nov27
Galmed Pharma released FY2025 Q3 earnings on November 26 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.3464 (forecast USD -0.54)
04:00
Galmed Pharma released FY2025 9 Months Earnings on November 26 Post-Market (EST), Actual Revenue USD 0, Actual EPS USD -1.5987
04:00
Oct29
Galmed Pharmaceuticals Annual General Meeting Proposals Passed
20:36
Aug29
Galmed Pharma released FY2025 Q2 earnings on August 28 (EST), actual revenue USD 0, actual EPS USD -0.6319 (forecast EPS USD -0.83)
03:00
Galmed Pharma released FY2025 Semi-Annual Earnings on August 28 (EST), actual revenue USD 0, actual EPS USD -1.2554
03:00

Schedules & Filings

Schedules
Filings
Nov26
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -1.892 M, EPS -0.3464

Aug28
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -2.495 M, EPS -0.6319

May22
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -1.104 M, EPS -0.6203

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
VMAR
0.9582
+152.09%
+0.584
AMCI
13.228
+81.95%
+6.060
SRXH
0.5325
+74.88%
+0.225
RILY
5.792
+55.70%
+2.060
CPAC
10.616
+51.87%
+3.626
EDHL
0.5447
+42.74%
+0.163
ADGM
1.138
+36.85%
+0.306
EEX
4.820
+36.16%
+1.280
PETS
3.890
+35.54%
+1.020
ALDX
5.375
+34.71%
+1.385
View More